About this Research Topic
The three-dimensional iridium-192 (192Ir) high-dose-rate (HDR) brachytherapy (BRT) manifests itself as a high precision, hypo-fractionated, dose-escalating, minimally invasive method in the armamentarium of contemporary Radiation Oncology clinical applications. HDR BRT has been enjoying rapid acceptance as a treatment modality offered to a variety of oncological scenarios both with curative and palliative intent in primary and metastatic sites. Evolutions in diagnosis paired with the implementation of radiomics and metabolomics has also driven this method even further.
The main purposes of this issue:
1) Introduce interstitial brachytherapy (including physical aspects and radiobiology)
2) Highlight the significance of local therapy with modern brachytherapy techniques as an alternative for stereotactic radiotherapy
3) Illuminate the different implementations of interstitial brachytherapy (curative and palliative intent)
4) Expand on the current diagnostic methods helping identify patients suitable for brachytherapy
We welcome Original Research, Case Reports, Reviews and Opinions as well as prospective trial initiatives regarding brachytherapy as monotherapy or in combination with other treatments.
--
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
The main purposes of this issue:
1) Introduce interstitial brachytherapy (including physical aspects and radiobiology)
2) Highlight the significance of local therapy with modern brachytherapy techniques as an alternative for stereotactic radiotherapy
3) Illuminate the different implementations of interstitial brachytherapy (curative and palliative intent)
4) Expand on the current diagnostic methods helping identify patients suitable for brachytherapy
We welcome Original Research, Case Reports, Reviews and Opinions as well as prospective trial initiatives regarding brachytherapy as monotherapy or in combination with other treatments.
--
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (clinical cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords: brachytherapy, radiation oncology, nuclear medicine, iridium knife, radiobiology, stereotactic radiotherapy
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
